Zomedica Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-33.64	-17.86	-18.38	-16.91	-19.78	-16.65	-8.07	-5.74
Depreciation & Amortization	0.83	0.43	0.27	0.31	0.79	0.2	0.09	0.05
Share-Based Compensation	6.26	7.89	7.09	1.66	3.33	5.66	1.12	1.48
Other Operating Activities	10.57	-2.13	-3.25	-1.29	0.03	-0.36	-0.25	-0.35
Operating Cash Flow	-15.98	-11.67	-14.28	-16.24	-15.63	-11.15	-7.09	-4.56
Capital Expenditures	-11.34	-2.55	-0.15	0.01	-0.16	-0.62	-0.17	-0.23
Acquisitions	-23.96	-24.3	-71.4	0	0	0	0	0
Change in Investments	41.03	-128.79	0	0	0	0	0	0
Other Investing Activities	-4.15	-0.24	-0.38	1	-0.53	-	-	-0.01
Investing Cash Flow	1.58	-155.88	-71.93	1.01	-0.69	-0.62	-0.17	-0.24
Share Issuance / Repurchase	0	0	187.02	52.38	2.29	10.26	7.49	4.68
Debt Issued / Paid	0	0	0	0	0	0	-0.01	0
Other Financing Activities	-	0.01	32.14	24.34	12.6	-	-	0.11
Financing Cash Flow	0	0.01	219.16	76.71	14.89	10.26	7.49	4.79
Exchange Rate Effect	-0.05	-0.01	0	0	0	0	0	0
Net Cash Flow	-14.4	-167.54	132.96	61.48	-1.43	-1.51	0.22	-0.02
Free Cash Flow	-27.31	-14.22	-14.42	-16.23	-15.79	-11.77	-7.26	-4.79
Free Cash Flow Margin	-108.45%	-75.12%	-348.97%	-	-	-	-	-
Free Cash Flow Per Share	-0.03	-0.01	-0.01	-0.04	-0.15	-0.13	-0.08	-0.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).